If you’re a pharmaceutical or medical device company, and you don’t know the litigation risks presented by one of your products, it can leave you vulnerable to blindsiding litigation. This webinar will introduce you to product liability risk assessments, an essential tool for life sciences companies. These assessments can be conducted before litigation begins (or before a product even comes to market), functioning as risk-mitigating due diligence investigations. If a company is already experiencing litigation, an assessment can help determine the risk of additional individual or class action lawsuits. And, assessments can also help would-be acquirers determine the liability a target product or company would carry.

Speakers: Barbara R. Binis Melissa A. Geist

Event Type: CLE / CPD, Webinar

Start Date/Time:
13 June 2018, 2:30 PM EDT
End Date/Time:
13 June 2018, 3:30 PM EDT

Our presenters are accomplished trial lawyers who have not only defended top life sciences companies in bet-the-company litigations, but have helped such companies limit their litigation and acquisition risks through product liability risk assessments.

Please log in 15 minutes prior to the start of the program.

This program is presumptively approved for 1.0 general CLE credit in California, Illinois, New Jersey, Pennsylvania, Texas and West Virginia. For lawyers licensed in New York, this course is eligible for 1.0 credit under New York’s Approved Jurisdiction Policy. Please allow four weeks after the program to receive a certificate of attendance.